In modern medicine, injections are one of the most frequently performed procedures. But even a standard medical needle can hide a risk: silicone oil residue. So why does this occur, how is it detected, and what methods are used as part of medical analysis to ensure safety?
Silicone oil is applied during needle manufacturing to reduce friction and ease skin penetration. While this improves comfort during injections, it may lead to complications if residue is not properly controlled.
Improperly applied or excessive silicone oil may enter the body, especially in sensitive procedures like intravitreal injections. Potential complications include:
As part of standard medical product testing, laboratories apply the following procedures:
The needle is rinsed with a solvent to extract surface silicone residues.
Concentration is measured using UV/VIS or IR spectroscopy.
Particulate silicone is examined under optical or electron microscopy.
Medical product tests ensure not just regulatory compliance but also patient safety. For single-use sterile devices, silicone particulates represent a real risk. Therefore, medical product analysis must include silicone oil residue checks.
International guidelines like ISO 11040-4, ISO 8871-1, and USP <797> define critical parameters for silicone oil application in medical devices. Compliance is mandatory for safe market release.
Preventing unseen risks in medical needles is only possible through expert medical analysis. Successful clinical outcomes depend on robust testing and product validation.
No. Proper application reduces this risk, but it should always be verified.
It is strongly recommended for high-risk procedures like ocular or intravenous injections.
Needles, syringes, cannulas, and intradermal injectors should all be tested.